Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 32Metastatic Castration-resistant Prostate Cancer 3Prostatic Diseases 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Urogenital Neoplasms 1Thrombocytopenia 1Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer Metastatic 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Metastatic Hormone Naive Prostate Cancer 1Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1Liver Neoplasms 1High-Risk Localized Prostate Cancer 1Glioma 1Glioblastoma 1Genital Neoplasms, Male 1Genital Diseases, Male 1Disease 1Cytopenia 1Carcinoma, Hepatocellular 1Carcinoma 1Astrocytoma 1Anemia 1

Interventions

padeliporfin 5Nivolumab 3entrectinib 2cobimetinib 2capmatinib 2atezolizumab 2anlotinib 2alectinib 2Vemurafenib 2Sunitinib 2Radiosurgery 2Cyclophosphamide 2Cisplatin 2Aspirin 2Ascorbic Acid 2trametinib 1spartalizumab 1relatlimab 1pertuzumab 1pembrolizumab 1palladium-bacteriopheophorbide 1olaparib 1niraparib 1nintedanib 1montanide ISA 51 1lutetium Lu 177 dotatate 1guadecitabine 1genexol-PM 1durvalumab 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms by Site × Pluvicto × Clear all
NCT05150236 2023-12-15

ANZUP2001

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Phase 2 Unknown
93 enrolled
Genitourinary

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡